Jump to content
Sign in to follow this  
LaurenH

Weekly Clip Report August 7

Recommended Posts

Here is the weekly clip report:

Healio
“FDA Grants Breakthrough Therapy Designation to Imfinzi for Non-Small Cell Lung Cancer”
https://www.healio.com/hematology-oncology/lung-cancer/news/online/{ff2af53b-37fe-4249-8680-63b558b163a7}/fda-grants-breakthrough-therapy-designation-to-imfinzi-for-non-small-cell-lung-cancer

Specialty Pharmacy Times
“Concurrent Chemotherapy, High-Dose Proton Beam Radiotherapy Show Promise in Advanced Lung Cancer”
https://www.specialtypharmacytimes.com/news/concurrent-chemotherapy-high-dose-proton-beam-radiotherapy-show-promise-in-advanced-lung-cancer

Medscape
“In Immunotherapy, Approved Biomarkers Pose Many Problems”
http://www.medscape.com/viewarticle/883451

Times Leader
“Dance Club Supports LUNGevity Foundation”
http://timesleader.com/community-features/669953/dance-club-supports-lungevity-foundation-4

Cancer Therapy Advisor
“Study Predicts Important Role for SABR in Treatment of Early-Stage NSCLC”
http://www.cancertherapyadvisor.com/lung-cancer/lung-cancer-nsclc-sabr-treatment-important-role/article/678775/

U.S. News & World Report
“Back Pain and Other Unusual Signs of Lung Cancer”
http://health.usnews.com/health-care/patient-advice/articles/2017-08-01/back-pain-and-other-unusual-signs-of-lung-cancer

New York Magazine
“Here’s What Not to Say to Someone with Cancer”
http://nymag.com/scienceofus/article/heres-what-not-to-say-to-someone-with-cancer.html

Targeted Oncology
“Options for Upfront Treatment of ALK-Rearranged NSCLC”
http://www.targetedonc.com/case-based-peer-perspectives/lung-cancer/langer-alk-nsclc/options-for-upfront-treatment-of-alk-rearranged-nsclc

Wicked Local – Scituate
“Scituate Man Throws Out Red Sox Pitch and Raises Awareness for Lung Cancer”
http://scituate.wickedlocal.com/news/20170803/scituate-man-throws-out-red-sox-pitch-and-raises-awareness-for-lung-cancer

OncLive
“FDA Grants Frontline Alectinib Priority Review for ALK-Positive NSCLC”
http://www.onclive.com/web-exclusives/fda-grants-frontline-alectinib-priority-review-for-alkpositive-nsclc

Cancer Network
“Concurrent Chemo, Proton Therapy Promising in Advanced Lung Cancer”
http://www.cancernetwork.com/news/concurrent-chemo-proton-therapy-promising-advanced-lung-cancer

Specialty Pharmacy Times
“FDA Grants Durvalumab Breakthrough Therapy Designation for Locally-Advanced Lung Cancer”
https://www.specialtypharmacytimes.com/news/fda-grants-durvalumab-breakthrough-therapy-designation-for-locally-advanced-lung-cancer

Everyday Health
“Five Reasons to Be Optimistic About Lung Cancer”
https://www.everydayhealth.com/lung-cancer/living-with/reasons-optimistic-about-lung-cancer/

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×